In the tumor microenvironment, cleaved nanoparticles release miR-497 and triptolide, which synergistically inhibit PI3K/AKT/mTOR signaling pathways and deplete glutathione to elevate intracellular reactive oxygen species (ROS). Here, AKT1 is linked to neoplasm.